JP2014501772A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014501772A5 JP2014501772A5 JP2013547865A JP2013547865A JP2014501772A5 JP 2014501772 A5 JP2014501772 A5 JP 2014501772A5 JP 2013547865 A JP2013547865 A JP 2013547865A JP 2013547865 A JP2013547865 A JP 2013547865A JP 2014501772 A5 JP2014501772 A5 JP 2014501772A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- pyrrolo
- diazaspiro
- octane
- pyrimidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 cyano, hydroxy Chemical group 0.000 claims 80
- 150000001875 compounds Chemical class 0.000 claims 38
- 125000000623 heterocyclic group Chemical group 0.000 claims 28
- 125000004404 heteroalkyl group Chemical group 0.000 claims 22
- 229910052739 hydrogen Inorganic materials 0.000 claims 22
- 239000001257 hydrogen Substances 0.000 claims 22
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 16
- 150000002431 hydrogen Chemical class 0.000 claims 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 14
- 125000004043 oxo group Chemical group O=* 0.000 claims 14
- 125000000217 alkyl group Chemical group 0.000 claims 13
- 229910052736 halogen Inorganic materials 0.000 claims 12
- 150000002367 halogens Chemical class 0.000 claims 12
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 12
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 10
- 125000003118 aryl group Chemical group 0.000 claims 10
- 125000001072 heteroaryl group Chemical group 0.000 claims 10
- 125000000753 cycloalkyl group Chemical group 0.000 claims 9
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 9
- 125000001424 substituent group Chemical group 0.000 claims 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 8
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 6
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 5
- 125000003342 alkenyl group Chemical group 0.000 claims 5
- 125000000304 alkynyl group Chemical group 0.000 claims 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 5
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 5
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 5
- 208000023275 Autoimmune disease Diseases 0.000 claims 4
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims 4
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 claims 4
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 claims 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims 4
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 4
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims 4
- 125000001153 fluoro group Chemical group F* 0.000 claims 4
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 4
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 3
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 claims 3
- 201000004624 Dermatitis Diseases 0.000 claims 3
- LKJPYSCBVHEWIU-UHFFFAOYSA-N N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide Chemical compound C=1C=C(C#N)C(C(F)(F)F)=CC=1NC(=O)C(O)(C)CS(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-UHFFFAOYSA-N 0.000 claims 3
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 claims 3
- 125000005160 aryl oxy alkyl group Chemical group 0.000 claims 3
- 125000002393 azetidinyl group Chemical group 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 3
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- 230000002458 infectious effect Effects 0.000 claims 3
- 208000027866 inflammatory disease Diseases 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 125000004399 C1-C4 alkenyl group Chemical group 0.000 claims 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims 2
- 102000042838 JAK family Human genes 0.000 claims 2
- 108091082332 JAK family Proteins 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 206010040799 Skin atrophy Diseases 0.000 claims 2
- 241000534944 Thia Species 0.000 claims 2
- 201000008937 atopic dermatitis Diseases 0.000 claims 2
- 208000010668 atopic eczema Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 claims 2
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 208000030533 eye disease Diseases 0.000 claims 2
- 125000005326 heteroaryloxy alkyl group Chemical group 0.000 claims 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 2
- 206010023332 keratitis Diseases 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- QWOKKHXWFDAJCZ-UHFFFAOYSA-N octane-1-sulfonamide Chemical compound CCCCCCCCS(N)(=O)=O QWOKKHXWFDAJCZ-UHFFFAOYSA-N 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 230000009759 skin aging Effects 0.000 claims 2
- 208000017520 skin disease Diseases 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000006526 (C1-C2) alkyl group Chemical group 0.000 claims 1
- 125000006532 (C3-C5) alkyl group Chemical group 0.000 claims 1
- 125000006555 (C3-C5) cycloalkyl group Chemical group 0.000 claims 1
- UPBPAKISEVOITE-MSXFZWOLSA-N (NZ)-N-[(4-methoxyphenyl)methylidene]-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1=CC(OC)=CC=C1\C=N/S(=O)(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 UPBPAKISEVOITE-MSXFZWOLSA-N 0.000 claims 1
- PIDLOAOWCYMMHN-UHFFFAOYSA-N 1-[[7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octan-4-yl]sulfonyl]piperidine-3-carbonitrile Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N1CCCC(C#N)C1 PIDLOAOWCYMMHN-UHFFFAOYSA-N 0.000 claims 1
- LJNYZRGQGRKNRP-UHFFFAOYSA-N 1-[[7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octan-4-yl]sulfonyl]piperidine-4-carbonitrile Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N1CCC(C#N)CC1 LJNYZRGQGRKNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims 1
- VGLIWKLNSIPDPO-UHFFFAOYSA-N 4-(4-imidazol-1-ylsulfonyl-4,7-diazaspiro[2.5]octan-7-yl)-7H-pyrrolo[2,3-d]pyrimidine Chemical compound C1=CN=CN1S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 VGLIWKLNSIPDPO-UHFFFAOYSA-N 0.000 claims 1
- PODDKJDNQSSKHD-UHFFFAOYSA-N 4-(4-piperidin-1-ylsulfonyl-4,7-diazaspiro[2.5]octan-7-yl)-7h-pyrrolo[2,3-d]pyrimidine Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N1CCCCC1 PODDKJDNQSSKHD-UHFFFAOYSA-N 0.000 claims 1
- OEXDCSYVQCRQNO-UHFFFAOYSA-N 7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound NS(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 OEXDCSYVQCRQNO-UHFFFAOYSA-N 0.000 claims 1
- JALJYLNIVJITOC-UHFFFAOYSA-N 7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonic acid Chemical compound OS(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 JALJYLNIVJITOC-UHFFFAOYSA-N 0.000 claims 1
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 1
- 208000026872 Addison Disease Diseases 0.000 claims 1
- 201000004384 Alopecia Diseases 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 206010002198 Anaphylactic reaction Diseases 0.000 claims 1
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 claims 1
- 208000033222 Biliary cirrhosis primary Diseases 0.000 claims 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 206010010741 Conjunctivitis Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 206010012442 Dermatitis contact Diseases 0.000 claims 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 claims 1
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 201000005569 Gout Diseases 0.000 claims 1
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
- 208000003084 Graves Ophthalmopathy Diseases 0.000 claims 1
- 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 claims 1
- 101000844245 Homo sapiens Non-receptor tyrosine-protein kinase TYK2 Proteins 0.000 claims 1
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 claims 1
- 101000934996 Homo sapiens Tyrosine-protein kinase JAK3 Proteins 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- NMMOWASTGBPHTO-UHFFFAOYSA-N N-(2,2-diphenylethyl)-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)NCC(C=1C=CC=CC=1)C1=CC=CC=C1 NMMOWASTGBPHTO-UHFFFAOYSA-N 0.000 claims 1
- XFYAOSWNQLKSOT-UHFFFAOYSA-N N-(2-methoxyethyl)-N-(2-phenylethyl)-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCOC)CCC1=CC=CC=C1 XFYAOSWNQLKSOT-UHFFFAOYSA-N 0.000 claims 1
- KSGABDOLZMZUQQ-UHFFFAOYSA-N N-(3-cyanopropyl)-N-(2-hydroxyethyl)-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound N#CCCCN(CCO)S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 KSGABDOLZMZUQQ-UHFFFAOYSA-N 0.000 claims 1
- QFVKMCJXZVMCSP-UHFFFAOYSA-N N-(3-cyanopropyl)-N-(2-phenylethyl)-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCCC#N)CCC1=CC=CC=C1 QFVKMCJXZVMCSP-UHFFFAOYSA-N 0.000 claims 1
- GZZHZUCELYUDTF-UHFFFAOYSA-N N-(3-cyanopropyl)-N-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound N#CCCCN(C)S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 GZZHZUCELYUDTF-UHFFFAOYSA-N 0.000 claims 1
- YFERPDDHNCYXOF-UHFFFAOYSA-N N-(azetidin-3-yl)-N-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C1CNC1 YFERPDDHNCYXOF-UHFFFAOYSA-N 0.000 claims 1
- AFOKHZQYRYCSGZ-UHFFFAOYSA-N N-(cyanomethyl)-N-[(1,1-dioxothian-4-yl)methyl]-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CC#N)CC1CCS(=O)(=O)CC1 AFOKHZQYRYCSGZ-UHFFFAOYSA-N 0.000 claims 1
- RHLWUNNBYOGZPF-UHFFFAOYSA-N N-[(1,1-dioxothian-4-yl)methyl]-N-(2-hydroxyethyl)-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCO)CC1CCS(=O)(=O)CC1 RHLWUNNBYOGZPF-UHFFFAOYSA-N 0.000 claims 1
- GTSKKXYSCFTTPE-UHFFFAOYSA-N N-[(1,1-dioxothiolan-3-yl)methyl]-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)NCC1CCS(=O)(=O)C1 GTSKKXYSCFTTPE-UHFFFAOYSA-N 0.000 claims 1
- RJVRCXVEEOIPDV-UHFFFAOYSA-N N-[(1,1-dioxothiolan-3-yl)methyl]-N-(2-hydroxyethyl)-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCO)CC1CCS(=O)(=O)C1 RJVRCXVEEOIPDV-UHFFFAOYSA-N 0.000 claims 1
- CBAWBLHQVSTOSY-UHFFFAOYSA-N N-[(1,1-dioxothiolan-3-yl)methyl]-N-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCS(=O)(=O)C1 CBAWBLHQVSTOSY-UHFFFAOYSA-N 0.000 claims 1
- RAFNKNDYDNGOAD-UHFFFAOYSA-N N-[(2-cyanophenyl)methyl]-N-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1=CC=CC=C1C#N RAFNKNDYDNGOAD-UHFFFAOYSA-N 0.000 claims 1
- VCFLUFTWBWEFFW-UHFFFAOYSA-N N-[(4-fluorophenyl)methyl]-N-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1=CC=C(F)C=C1 VCFLUFTWBWEFFW-UHFFFAOYSA-N 0.000 claims 1
- BKMPNDMVBLLYPY-UHFFFAOYSA-N N-[2-(4-fluorophenyl)ethyl]-N-(2-phenylethyl)-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1=CC(F)=CC=C1CCN(S(=O)(=O)N1C2(CC2)CN(CC1)C=1C=2C=CNC=2N=CN=1)CCC1=CC=CC=C1 BKMPNDMVBLLYPY-UHFFFAOYSA-N 0.000 claims 1
- DYWAFADPHCTOEP-UHFFFAOYSA-N N-[3-(3-cyanophenyl)propyl]-N-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCCC1=CC=CC(C#N)=C1 DYWAFADPHCTOEP-UHFFFAOYSA-N 0.000 claims 1
- FRGOJTCBTIPUFW-UHFFFAOYSA-N N-[3-(4-cyanophenyl)propyl]-N-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCCC1=CC=C(C#N)C=C1 FRGOJTCBTIPUFW-UHFFFAOYSA-N 0.000 claims 1
- CFXKIKUOOYKOGW-KRWDZBQOSA-N N-[[(2S)-1-(3-cyanopropylsulfonyl)-4,4-difluoropyrrolidin-2-yl]methyl]-N-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@@H]1CC(F)(F)CN1S(=O)(=O)CCCC#N CFXKIKUOOYKOGW-KRWDZBQOSA-N 0.000 claims 1
- ULRRKTYCONSYMA-HNNXBMFYSA-N N-[[(2S)-4,4-difluoro-1-(3-hydroxypropanoyl)pyrrolidin-2-yl]methyl]-N-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@@H]1CC(F)(F)CN1C(=O)CCO ULRRKTYCONSYMA-HNNXBMFYSA-N 0.000 claims 1
- HDMGZGMCZKCJEP-AWEZNQCLSA-N N-[[(2S)-4,4-difluoro-1-formylpyrrolidin-2-yl]methyl]-N-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@@H]1CC(F)(F)CN1C=O HDMGZGMCZKCJEP-AWEZNQCLSA-N 0.000 claims 1
- BBKNDPZTJPDRKJ-UHFFFAOYSA-N N-[[1-(3-cyanopropanoyl)piperidin-4-yl]methyl]-N-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCN(C(=O)CCC#N)CC1 BBKNDPZTJPDRKJ-UHFFFAOYSA-N 0.000 claims 1
- VUELUIFCCDJRAJ-UHFFFAOYSA-N N-[[2-(2,2-difluoroethyl)-1,5-dihydropyrazol-5-yl]methyl]-N-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1NN(CC(F)F)C=C1 VUELUIFCCDJRAJ-UHFFFAOYSA-N 0.000 claims 1
- AXIKLLWMQWXJLL-UHFFFAOYSA-N N-[[2-(difluoromethyl)-1,5-dihydropyrazol-5-yl]methyl]-N-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1NN(C(F)F)C=C1 AXIKLLWMQWXJLL-UHFFFAOYSA-N 0.000 claims 1
- IHSSPJIVZWYYOV-UHFFFAOYSA-N N-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1=CC=C(C(F)(F)F)C=C1 IHSSPJIVZWYYOV-UHFFFAOYSA-N 0.000 claims 1
- 201000011152 Pemphigus Diseases 0.000 claims 1
- 208000031845 Pernicious anaemia Diseases 0.000 claims 1
- 206010036105 Polyneuropathy Diseases 0.000 claims 1
- 208000012654 Primary biliary cholangitis Diseases 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 claims 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 claims 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 claims 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 1
- 241001303601 Rosacea Species 0.000 claims 1
- BIJCAMGRYZKROR-UHFFFAOYSA-N S1CC(CCC1)C(=O)N Chemical compound S1CC(CCC1)C(=O)N BIJCAMGRYZKROR-UHFFFAOYSA-N 0.000 claims 1
- 206010039705 Scleritis Diseases 0.000 claims 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- 206010042742 Sympathetic ophthalmia Diseases 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 claims 1
- 102100025387 Tyrosine-protein kinase JAK3 Human genes 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 208000024780 Urticaria Diseases 0.000 claims 1
- 206010046851 Uveitis Diseases 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 206010069351 acute lung injury Diseases 0.000 claims 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 230000000172 allergic effect Effects 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 231100000360 alopecia Toxicity 0.000 claims 1
- 230000036783 anaphylactic response Effects 0.000 claims 1
- 208000003455 anaphylaxis Diseases 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 230000001363 autoimmune Effects 0.000 claims 1
- 201000005000 autoimmune gastritis Diseases 0.000 claims 1
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 claims 1
- 208000010928 autoimmune thyroid disease Diseases 0.000 claims 1
- 125000004567 azetidin-3-yl group Chemical group N1CC(C1)* 0.000 claims 1
- 208000010217 blepharitis Diseases 0.000 claims 1
- DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000002837 carbocyclic group Chemical group 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000030949 chronic idiopathic urticaria Diseases 0.000 claims 1
- 208000037976 chronic inflammation Diseases 0.000 claims 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 claims 1
- 208000025302 chronic primary adrenal insufficiency Diseases 0.000 claims 1
- 206010072757 chronic spontaneous urticaria Diseases 0.000 claims 1
- 208000024376 chronic urticaria Diseases 0.000 claims 1
- 230000007882 cirrhosis Effects 0.000 claims 1
- 208000019425 cirrhosis of liver Diseases 0.000 claims 1
- 208000010247 contact dermatitis Diseases 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- PNZXMIKHJXIPEK-UHFFFAOYSA-N cyclohexanecarboxamide Chemical compound NC(=O)C1CCCCC1 PNZXMIKHJXIPEK-UHFFFAOYSA-N 0.000 claims 1
- XRLDSWLMHUQECH-UHFFFAOYSA-N cyclopentanecarboxamide Chemical compound NC(=O)C1CCCC1 XRLDSWLMHUQECH-UHFFFAOYSA-N 0.000 claims 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- JGHFRGJGSGRUHV-UHFFFAOYSA-N ethyl 2-[2-phenylethyl-[[7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octan-4-yl]sulfonyl]amino]acetate Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CC(=O)OCC)CCC1=CC=CC=C1 JGHFRGJGSGRUHV-UHFFFAOYSA-N 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 210000000987 immune system Anatomy 0.000 claims 1
- 208000026278 immune system disease Diseases 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 201000004614 iritis Diseases 0.000 claims 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 201000010666 keratoconjunctivitis Diseases 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 206010025135 lupus erythematosus Diseases 0.000 claims 1
- 201000003265 lymphadenitis Diseases 0.000 claims 1
- 208000002780 macular degeneration Diseases 0.000 claims 1
- VJWGOFWWFKQZDA-UHFFFAOYSA-N methyl 2-[methyl-[[7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octan-4-yl]sulfonyl]amino]acetate Chemical compound COC(=O)CN(C)S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 VJWGOFWWFKQZDA-UHFFFAOYSA-N 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- 206010028417 myasthenia gravis Diseases 0.000 claims 1
- HAKIEOJHJVCDIL-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound OCCN(CCO)S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 HAKIEOJHJVCDIL-UHFFFAOYSA-N 0.000 claims 1
- DNORSFDDCWTUFQ-UHFFFAOYSA-N n,n-bis(3-cyanopropyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound N#CCCCN(CCCC#N)S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 DNORSFDDCWTUFQ-UHFFFAOYSA-N 0.000 claims 1
- KWMPMCMYYNOWGJ-UHFFFAOYSA-N n,n-bis(cyanomethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound N#CCN(CC#N)S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 KWMPMCMYYNOWGJ-UHFFFAOYSA-N 0.000 claims 1
- SIYUZCGZDKSFNK-UHFFFAOYSA-N n,n-dibenzyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CC=1C=CC=CC=1)CC1=CC=CC=C1 SIYUZCGZDKSFNK-UHFFFAOYSA-N 0.000 claims 1
- NMEYIHPSPMHXGR-UHFFFAOYSA-N n,n-dimethyl-2-[methyl-[[7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octan-4-yl]sulfonyl]amino]acetamide Chemical compound CN(C)C(=O)CN(C)S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 NMEYIHPSPMHXGR-UHFFFAOYSA-N 0.000 claims 1
- BVRCTLKZFRJXRZ-UHFFFAOYSA-N n,n-dimethyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound CN(C)S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 BVRCTLKZFRJXRZ-UHFFFAOYSA-N 0.000 claims 1
- ONJDUXKJPCMQQQ-UHFFFAOYSA-N n-(1-cyanoethyl)-n-(oxetan-3-yl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C(C#N)C)C1COC1 ONJDUXKJPCMQQQ-UHFFFAOYSA-N 0.000 claims 1
- IVHIFERCGYSOJC-UHFFFAOYSA-N n-(1-cyanoethyl)-n-cyclobutyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C(C#N)C)C1CCC1 IVHIFERCGYSOJC-UHFFFAOYSA-N 0.000 claims 1
- LAMDLDINYNPXRE-UHFFFAOYSA-N n-(2-cyanoethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound N#CCCNS(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 LAMDLDINYNPXRE-UHFFFAOYSA-N 0.000 claims 1
- AKCHNGMARMCTRL-UHFFFAOYSA-N n-(2-cyanoethyl)-n-(cyanomethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound N#CCCN(CC#N)S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 AKCHNGMARMCTRL-UHFFFAOYSA-N 0.000 claims 1
- BIUAPLZVGLZVPH-UHFFFAOYSA-N n-(2-cyanoethyl)-n-(oxolan-2-ylmethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCC#N)CC1CCCO1 BIUAPLZVGLZVPH-UHFFFAOYSA-N 0.000 claims 1
- VPSXOPWYBDTTPU-UHFFFAOYSA-N n-(2-cyanoethyl)-n-cyclopropyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCC#N)C1CC1 VPSXOPWYBDTTPU-UHFFFAOYSA-N 0.000 claims 1
- ICZGHMFIOVJIKB-UHFFFAOYSA-N n-(2-cyclohexylethyl)-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCC1CCCCC1 ICZGHMFIOVJIKB-UHFFFAOYSA-N 0.000 claims 1
- ATNZFGAQUNLOJV-UHFFFAOYSA-N n-(2-cyclopentylethyl)-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCC1CCCC1 ATNZFGAQUNLOJV-UHFFFAOYSA-N 0.000 claims 1
- SUHHXRISGRZNAI-UHFFFAOYSA-N n-(2-cyclopropylethyl)-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCC1CC1 SUHHXRISGRZNAI-UHFFFAOYSA-N 0.000 claims 1
- XDBNIYMUBIDISM-UHFFFAOYSA-N n-(2-hydroxyethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound OCCNS(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 XDBNIYMUBIDISM-UHFFFAOYSA-N 0.000 claims 1
- CFFBZLZRTUWJKT-UHFFFAOYSA-N n-(2-hydroxyethyl)-n-(2-phenoxyethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCO)CCOC1=CC=CC=C1 CFFBZLZRTUWJKT-UHFFFAOYSA-N 0.000 claims 1
- JSEVRNJZODIHEC-UHFFFAOYSA-N n-(2-hydroxyethyl)-n-(2-phenylethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCO)CCC1=CC=CC=C1 JSEVRNJZODIHEC-UHFFFAOYSA-N 0.000 claims 1
- OECLDTONENJAAP-UHFFFAOYSA-N n-(2-hydroxyethyl)-n-(oxetan-3-yl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCO)C1COC1 OECLDTONENJAAP-UHFFFAOYSA-N 0.000 claims 1
- MOTFWHWYWQVXRV-UHFFFAOYSA-N n-(2-hydroxyethyl)-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound OCCN(C)S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 MOTFWHWYWQVXRV-UHFFFAOYSA-N 0.000 claims 1
- YEXDARNQPFGTOB-UHFFFAOYSA-N n-(2-hydroxyethyl)-n-propan-2-yl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound OCCN(C(C)C)S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 YEXDARNQPFGTOB-UHFFFAOYSA-N 0.000 claims 1
- OXLLIFVNWVIAQB-UHFFFAOYSA-N n-(2-methylpropyl)-n-(2-phenylethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CC(C)C)CCC1=CC=CC=C1 OXLLIFVNWVIAQB-UHFFFAOYSA-N 0.000 claims 1
- UWMSPUUIHLRSFV-UHFFFAOYSA-N n-(2-oxobutyl)-n-(2-phenylethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CC(=O)CC)CCC1=CC=CC=C1 UWMSPUUIHLRSFV-UHFFFAOYSA-N 0.000 claims 1
- QPZVZKSXBBMCRM-UHFFFAOYSA-N n-(2-phenylethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)NCCC1=CC=CC=C1 QPZVZKSXBBMCRM-UHFFFAOYSA-N 0.000 claims 1
- YKPBEWKMOVHBLR-UHFFFAOYSA-N n-(2-phenylethyl)-n-(2-pyrazol-1-ylethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCN1N=CC=C1)CCC1=CC=CC=C1 YKPBEWKMOVHBLR-UHFFFAOYSA-N 0.000 claims 1
- IBLNEBOCMPEHLE-UHFFFAOYSA-N n-(2-phenylethyl)-n-(3-phenylpropyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCC=1C=CC=CC=1)CCCC1=CC=CC=C1 IBLNEBOCMPEHLE-UHFFFAOYSA-N 0.000 claims 1
- PTSWVAXXEMTETP-UHFFFAOYSA-N n-(2-phenylethyl)-n-propyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCC)CCC1=CC=CC=C1 PTSWVAXXEMTETP-UHFFFAOYSA-N 0.000 claims 1
- WZFXRNWVRCNKPF-UHFFFAOYSA-N n-(3-cyanopropyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound N#CCCCNS(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 WZFXRNWVRCNKPF-UHFFFAOYSA-N 0.000 claims 1
- ACOPWBKJITVHHX-UHFFFAOYSA-N n-(3-cyanopropyl)-n-(3-phenylpropyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCCC#N)CCCC1=CC=CC=C1 ACOPWBKJITVHHX-UHFFFAOYSA-N 0.000 claims 1
- TUFJRSOOHSNCSD-UHFFFAOYSA-N n-(3-cyanopropyl)-n-(oxetan-3-yl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCCC#N)C1COC1 TUFJRSOOHSNCSD-UHFFFAOYSA-N 0.000 claims 1
- XANXFARMEPQEHF-UHFFFAOYSA-N n-(3-cyanopropyl)-n-cyclobutyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCCC#N)C1CCC1 XANXFARMEPQEHF-UHFFFAOYSA-N 0.000 claims 1
- GQDWVMLGHJQKNE-UHFFFAOYSA-N n-(3-hydroxypropyl)-n-(2-phenylethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCCO)CCC1=CC=CC=C1 GQDWVMLGHJQKNE-UHFFFAOYSA-N 0.000 claims 1
- NYVSWDGDOBILKU-UHFFFAOYSA-N n-(cyanomethyl)-n-(2-phenylethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CC#N)CCC1=CC=CC=C1 NYVSWDGDOBILKU-UHFFFAOYSA-N 0.000 claims 1
- RQMANJRNNHJGTK-UHFFFAOYSA-N n-(cyanomethyl)-n-(oxetan-3-yl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CC#N)C1COC1 RQMANJRNNHJGTK-UHFFFAOYSA-N 0.000 claims 1
- JUNDGRBHJRMMPA-UHFFFAOYSA-N n-(cyanomethyl)-n-[(1,1-dioxothiolan-3-yl)methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CC#N)CC1CCS(=O)(=O)C1 JUNDGRBHJRMMPA-UHFFFAOYSA-N 0.000 claims 1
- NICFBFHTBZISBG-UHFFFAOYSA-N n-(cyanomethyl)-n-cyclobutyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CC#N)C1CCC1 NICFBFHTBZISBG-UHFFFAOYSA-N 0.000 claims 1
- IOJSBENOGFHMSY-UHFFFAOYSA-N n-(cyanomethyl)-n-propan-2-yl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound N#CCN(C(C)C)S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 IOJSBENOGFHMSY-UHFFFAOYSA-N 0.000 claims 1
- DCNSJGOMFIRNTM-UHFFFAOYSA-N n-(cyclobutylmethyl)-n-(2-phenylethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CC1CCC1)CCC1=CC=CC=C1 DCNSJGOMFIRNTM-UHFFFAOYSA-N 0.000 claims 1
- YOCSHVIPBWMION-UHFFFAOYSA-N n-(cyclobutylmethyl)-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCC1 YOCSHVIPBWMION-UHFFFAOYSA-N 0.000 claims 1
- RFLHUCDNNJIDAA-UHFFFAOYSA-N n-(cyclohexylmethyl)-n-(2-phenylethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CC1CCCCC1)CCC1=CC=CC=C1 RFLHUCDNNJIDAA-UHFFFAOYSA-N 0.000 claims 1
- CGLYHBLGNIBKOO-UHFFFAOYSA-N n-(cyclohexylmethyl)-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCCCC1 CGLYHBLGNIBKOO-UHFFFAOYSA-N 0.000 claims 1
- WWUIOYQXZCNABQ-UHFFFAOYSA-N n-(cyclopentylmethyl)-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCCC1 WWUIOYQXZCNABQ-UHFFFAOYSA-N 0.000 claims 1
- OGFCLXVEUGEEII-UHFFFAOYSA-N n-(cyclopropylmethyl)-n-(2-phenylethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CC1CC1)CCC1=CC=CC=C1 OGFCLXVEUGEEII-UHFFFAOYSA-N 0.000 claims 1
- XWPDTEIVYWUYOI-UHFFFAOYSA-N n-(cyclopropylmethyl)-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CC1 XWPDTEIVYWUYOI-UHFFFAOYSA-N 0.000 claims 1
- VEUWFKFJIDJALQ-UHFFFAOYSA-N n-(oxan-2-ylmethyl)-n-(2-phenylethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CC1OCCCC1)CCC1=CC=CC=C1 VEUWFKFJIDJALQ-UHFFFAOYSA-N 0.000 claims 1
- VQKZKHDZCOJNEJ-UHFFFAOYSA-N n-(oxetan-3-yl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)NC1COC1 VQKZKHDZCOJNEJ-UHFFFAOYSA-N 0.000 claims 1
- FVMUJPDIKURLRE-UHFFFAOYSA-N n-(oxetan-3-yl)-n-(2-phenoxyethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C1COC1)CCOC1=CC=CC=C1 FVMUJPDIKURLRE-UHFFFAOYSA-N 0.000 claims 1
- QZCWVDFYUVZLOE-UHFFFAOYSA-N n-[(1,1-dioxothian-3-yl)methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCCS(=O)(=O)C1 QZCWVDFYUVZLOE-UHFFFAOYSA-N 0.000 claims 1
- YJUQDNGJUALGNC-UHFFFAOYSA-N n-[(1,1-dioxothian-4-yl)methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)NCC1CCS(=O)(=O)CC1 YJUQDNGJUALGNC-UHFFFAOYSA-N 0.000 claims 1
- LHZMCYYUISIKCP-UHFFFAOYSA-N n-[(1,1-dioxothian-4-yl)methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCS(=O)(=O)CC1 LHZMCYYUISIKCP-UHFFFAOYSA-N 0.000 claims 1
- VZMOUDKNFDGYAK-UHFFFAOYSA-N n-[(1-formylpyrrolidin-3-yl)methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCN(C=O)C1 VZMOUDKNFDGYAK-UHFFFAOYSA-N 0.000 claims 1
- YUTJNOBDAQEGDI-UHFFFAOYSA-N n-[(2,2-difluorocyclopropyl)methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CC1(F)F YUTJNOBDAQEGDI-UHFFFAOYSA-N 0.000 claims 1
- HJTCDJXGYYUHTB-UHFFFAOYSA-N n-[(2-fluorophenyl)methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1=CC=CC=C1F HJTCDJXGYYUHTB-UHFFFAOYSA-N 0.000 claims 1
- SPMXMUUWHSTVNZ-UHFFFAOYSA-N n-[(3,3-difluorocyclobutyl)methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CC(F)(F)C1 SPMXMUUWHSTVNZ-UHFFFAOYSA-N 0.000 claims 1
- HRADOEZPBWGFQO-UHFFFAOYSA-N n-[(3-cyanophenyl)methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1=CC=CC(C#N)=C1 HRADOEZPBWGFQO-UHFFFAOYSA-N 0.000 claims 1
- ISZKDSFWTVXKEF-UHFFFAOYSA-N n-[(3-fluorophenyl)methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1=CC=CC(F)=C1 ISZKDSFWTVXKEF-UHFFFAOYSA-N 0.000 claims 1
- FHZSSVVAFHRPBF-UHFFFAOYSA-N n-[(4,4-difluorocyclohexyl)methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CC(F)(F)CCC1CNS(=O)(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 FHZSSVVAFHRPBF-UHFFFAOYSA-N 0.000 claims 1
- UTEWAPMHZXUCTB-UHFFFAOYSA-N n-[(4,4-difluorocyclohexyl)methyl]-n-ethyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CC)CC1CCC(F)(F)CC1 UTEWAPMHZXUCTB-UHFFFAOYSA-N 0.000 claims 1
- AXCRXYDVQZNBOX-UHFFFAOYSA-N n-[(4,4-difluorocyclohexyl)methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCC(F)(F)CC1 AXCRXYDVQZNBOX-UHFFFAOYSA-N 0.000 claims 1
- YVUFJUFLVIVBHA-UHFFFAOYSA-N n-[(4-cyanocuban-1-yl)methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound N#CC12C3C4C2C2C1C3C24CN(C)S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 YVUFJUFLVIVBHA-UHFFFAOYSA-N 0.000 claims 1
- JBQQYFNYVHVADI-UHFFFAOYSA-N n-[(4-methoxyphenyl)methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1=CC(OC)=CC=C1CNS(=O)(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 JBQQYFNYVHVADI-UHFFFAOYSA-N 0.000 claims 1
- RSGVWZUYASWQCB-UHFFFAOYSA-N n-[(4-tert-butylcyclohexyl)methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCC(C(C)(C)C)CC1 RSGVWZUYASWQCB-UHFFFAOYSA-N 0.000 claims 1
- RBXGTNPGSJLARK-UHFFFAOYSA-N n-[1-(3-hydroxypropanoyl)azetidin-3-yl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C1CN(C(=O)CCO)C1 RBXGTNPGSJLARK-UHFFFAOYSA-N 0.000 claims 1
- HWWQPMHGMJYQBX-UHFFFAOYSA-N n-[2-(1,1-dioxothiolan-3-yl)ethyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCC1CCS(=O)(=O)C1 HWWQPMHGMJYQBX-UHFFFAOYSA-N 0.000 claims 1
- BWWHRNNDHFETGY-UHFFFAOYSA-N n-[2-(2-cyanophenoxy)ethyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCOC1=CC=CC=C1C#N BWWHRNNDHFETGY-UHFFFAOYSA-N 0.000 claims 1
- QXWOWCWDETVASJ-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)S(=O)(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 QXWOWCWDETVASJ-UHFFFAOYSA-N 0.000 claims 1
- LWDVNFXFFBROII-UHFFFAOYSA-N n-[2-(3,5-dimethyl-1,2-oxazol-4-yl)ethyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCC=1C(C)=NOC=1C LWDVNFXFFBROII-UHFFFAOYSA-N 0.000 claims 1
- GKNYDHLHNZPDEH-UHFFFAOYSA-N n-[2-(3-cyanophenoxy)ethyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCOC1=CC=CC(C#N)=C1 GKNYDHLHNZPDEH-UHFFFAOYSA-N 0.000 claims 1
- QLEXWXLIXRPSAI-UHFFFAOYSA-N n-[2-(3-fluorophenyl)ethyl]-n-(2-phenylethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound FC1=CC=CC(CCN(CCC=2C=CC=CC=2)S(=O)(=O)N2C3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)=C1 QLEXWXLIXRPSAI-UHFFFAOYSA-N 0.000 claims 1
- KGQSNZCHXMVUOG-UHFFFAOYSA-N n-[2-(3-fluorophenyl)ethyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCC1=CC=CC(F)=C1 KGQSNZCHXMVUOG-UHFFFAOYSA-N 0.000 claims 1
- MYUXLKVLFFVJOE-UHFFFAOYSA-N n-[2-(4-chlorophenoxy)ethyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCOC1=CC=C(Cl)C=C1 MYUXLKVLFFVJOE-UHFFFAOYSA-N 0.000 claims 1
- XWOHIVREEIWKFO-UHFFFAOYSA-N n-[2-(4-cyanophenoxy)ethyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCOC1=CC=C(C#N)C=C1 XWOHIVREEIWKFO-UHFFFAOYSA-N 0.000 claims 1
- PGIWJLXKPPEEIK-UHFFFAOYSA-N n-[2-(4-fluorophenyl)ethyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCC1=CC=C(F)C=C1 PGIWJLXKPPEEIK-UHFFFAOYSA-N 0.000 claims 1
- YKNUUZAYMADJRY-LDCVWXEPSA-N n-[[(2r)-1-(2,3-dihydroxypropanoyl)pyrrolidin-2-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@H]1CCCN1C(=O)C(O)CO YKNUUZAYMADJRY-LDCVWXEPSA-N 0.000 claims 1
- HHVBSINVBMCTHX-MRXNPFEDSA-N n-[[(2r)-1-(2-cyanoacetyl)pyrrolidin-2-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@H]1CCCN1C(=O)CC#N HHVBSINVBMCTHX-MRXNPFEDSA-N 0.000 claims 1
- LETIGEUQCHTFEP-OAHLLOKOSA-N n-[[(2r)-1-(2-hydroxyacetyl)pyrrolidin-2-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@H]1CCCN1C(=O)CO LETIGEUQCHTFEP-OAHLLOKOSA-N 0.000 claims 1
- NHRCAZVIQFZGRF-QGZVFWFLSA-N n-[[(2r)-1-(3-cyanopropanoyl)pyrrolidin-2-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@H]1CCCN1C(=O)CCC#N NHRCAZVIQFZGRF-QGZVFWFLSA-N 0.000 claims 1
- WMDMSPZICXIFPA-GOSISDBHSA-N n-[[(2r)-1-(3-cyanopropylsulfonyl)pyrrolidin-2-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@H]1CCCN1S(=O)(=O)CCCC#N WMDMSPZICXIFPA-GOSISDBHSA-N 0.000 claims 1
- MVOYGCXBJNKIAH-MRXNPFEDSA-N n-[[(2r)-1-(3-hydroxypropanoyl)pyrrolidin-2-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@H]1CCCN1C(=O)CCO MVOYGCXBJNKIAH-MRXNPFEDSA-N 0.000 claims 1
- XSKPFWRMXQQJSH-OAHLLOKOSA-N n-[[(2r)-1-formylpyrrolidin-2-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@H]1CCCN1C=O XSKPFWRMXQQJSH-OAHLLOKOSA-N 0.000 claims 1
- LETIGEUQCHTFEP-HNNXBMFYSA-N n-[[(2s)-1-(2-hydroxyacetyl)pyrrolidin-2-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@@H]1CCCN1C(=O)CO LETIGEUQCHTFEP-HNNXBMFYSA-N 0.000 claims 1
- UHLWUOGTPVXWQG-INIZCTEOSA-N n-[[(2s)-1-(3-cyanopropanoyl)-4,4-difluoropyrrolidin-2-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@@H]1CC(F)(F)CN1C(=O)CCC#N UHLWUOGTPVXWQG-INIZCTEOSA-N 0.000 claims 1
- MVOYGCXBJNKIAH-INIZCTEOSA-N n-[[(2s)-1-(3-hydroxypropanoyl)pyrrolidin-2-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@@H]1CCCN1C(=O)CCO MVOYGCXBJNKIAH-INIZCTEOSA-N 0.000 claims 1
- AUGZVODVVIWPRS-KRWDZBQOSA-N n-[[(2s)-1-(cyclopropylmethylsulfonyl)-4,4-difluoropyrrolidin-2-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C([C@H]1CN(C)S(=O)(=O)N2C3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)C(F)(F)CN1S(=O)(=O)CC1CC1 AUGZVODVVIWPRS-KRWDZBQOSA-N 0.000 claims 1
- MVYSFSRTFBYGAR-FQEVSTJZSA-N n-[[(2s)-1-benzylpyrrolidin-2-yl]methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C([C@H]1CNS(=O)(=O)N2C3(CC3)CN(CC2)C=2C=3C=CNC=3N=CN=2)CCN1CC1=CC=CC=C1 MVYSFSRTFBYGAR-FQEVSTJZSA-N 0.000 claims 1
- XSKPFWRMXQQJSH-HNNXBMFYSA-N n-[[(2s)-1-formylpyrrolidin-2-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@@H]1CCCN1C=O XSKPFWRMXQQJSH-HNNXBMFYSA-N 0.000 claims 1
- DCEYWCQZJOCRDS-ZDUSSCGKSA-N n-[[(2s)-4,4-difluoropyrrolidin-2-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@@H]1CC(F)(F)CN1 DCEYWCQZJOCRDS-ZDUSSCGKSA-N 0.000 claims 1
- XCPYOUGGKWUHOW-UHFFFAOYSA-N n-[[1-(2,3-dihydroxypropanoyl)pyrrolidin-3-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCN(C(=O)C(O)CO)C1 XCPYOUGGKWUHOW-UHFFFAOYSA-N 0.000 claims 1
- ARBFEUQRIGCQJU-UHFFFAOYSA-N n-[[1-(2-methoxyethylsulfonyl)pyrrolidin-3-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1N(S(=O)(=O)CCOC)CCC1CN(C)S(=O)(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 ARBFEUQRIGCQJU-UHFFFAOYSA-N 0.000 claims 1
- WPHRHCUDCJICLO-UHFFFAOYSA-N n-[[1-(3-cyanopropanoyl)piperidin-3-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCCN(C(=O)CCC#N)C1 WPHRHCUDCJICLO-UHFFFAOYSA-N 0.000 claims 1
- OKVIITAWWYMYRK-UHFFFAOYSA-N n-[[1-(3-cyanopropanoyl)pyrrolidin-3-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCN(C(=O)CCC#N)C1 OKVIITAWWYMYRK-UHFFFAOYSA-N 0.000 claims 1
- FOABUQIIFGCKNO-UHFFFAOYSA-N n-[[1-(3-cyanopropylsulfonyl)piperidin-3-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCCN(S(=O)(=O)CCCC#N)C1 FOABUQIIFGCKNO-UHFFFAOYSA-N 0.000 claims 1
- WSQBVWSWIUICFE-UHFFFAOYSA-N n-[[1-(3-cyanopropylsulfonyl)piperidin-4-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCN(S(=O)(=O)CCCC#N)CC1 WSQBVWSWIUICFE-UHFFFAOYSA-N 0.000 claims 1
- WPYITIBVPBODMJ-UHFFFAOYSA-N n-[[1-(3-cyanopropylsulfonyl)pyrrolidin-3-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCN(S(=O)(=O)CCCC#N)C1 WPYITIBVPBODMJ-UHFFFAOYSA-N 0.000 claims 1
- MNZVCSRXNWIVBD-UHFFFAOYSA-N n-[[1-(3-hydroxybutanoyl)pyrrolidin-3-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1N(C(=O)CC(O)C)CCC1CN(C)S(=O)(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 MNZVCSRXNWIVBD-UHFFFAOYSA-N 0.000 claims 1
- YDSPBUNWQRWBRP-UHFFFAOYSA-N n-[[1-(3-hydroxypropanoyl)piperidin-3-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCCN(C(=O)CCO)C1 YDSPBUNWQRWBRP-UHFFFAOYSA-N 0.000 claims 1
- MCKFJVGLAUJHSX-UHFFFAOYSA-N n-[[1-(3-hydroxypropanoyl)piperidin-4-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCN(C(=O)CCO)CC1 MCKFJVGLAUJHSX-UHFFFAOYSA-N 0.000 claims 1
- AVCBPBZGYCYCGR-UHFFFAOYSA-N n-[[1-(3-hydroxypropanoyl)pyrrolidin-3-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCN(C(=O)CCO)C1 AVCBPBZGYCYCGR-UHFFFAOYSA-N 0.000 claims 1
- PXJDMVNXPYNFBV-UHFFFAOYSA-N n-[[1-(cyclopropylmethylsulfonyl)pyrrolidin-3-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC(C1)CCN1S(=O)(=O)CC1CC1 PXJDMVNXPYNFBV-UHFFFAOYSA-N 0.000 claims 1
- RQCMCKFZYROOTM-UHFFFAOYSA-N n-[[5-(dimethylsulfamoyl)furan-2-yl]methyl]-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound O1C(S(=O)(=O)N(C)C)=CC=C1CN(C)S(=O)(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 RQCMCKFZYROOTM-UHFFFAOYSA-N 0.000 claims 1
- XCSUFNKLTGYLGI-UHFFFAOYSA-N n-[[7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octan-4-yl]sulfonyl]formamide Chemical compound O=CNS(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 XCSUFNKLTGYLGI-UHFFFAOYSA-N 0.000 claims 1
- CGWJSGNPPJYAML-UHFFFAOYSA-N n-benzyl-2-[2-phenylethyl-[[7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octan-4-yl]sulfonyl]amino]acetamide Chemical compound C=1C=CC=CC=1CNC(=O)CN(S(=O)(=O)N1C2(CC2)CN(CC1)C=1C=2C=CNC=2N=CN=1)CCC1=CC=CC=C1 CGWJSGNPPJYAML-UHFFFAOYSA-N 0.000 claims 1
- KEONGVXNLBBNIL-UHFFFAOYSA-N n-benzyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)NCC1=CC=CC=C1 KEONGVXNLBBNIL-UHFFFAOYSA-N 0.000 claims 1
- CFQGNFZUKREFNE-UHFFFAOYSA-N n-benzyl-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1=CC=CC=C1 CFQGNFZUKREFNE-UHFFFAOYSA-N 0.000 claims 1
- UAUSGHZYCFDFOG-UHFFFAOYSA-N n-but-2-ynyl-n-(2-phenylethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CC#CC)CCC1=CC=CC=C1 UAUSGHZYCFDFOG-UHFFFAOYSA-N 0.000 claims 1
- JJIIWABQMOCAJY-UHFFFAOYSA-N n-cyclobutyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)NC1CCC1 JJIIWABQMOCAJY-UHFFFAOYSA-N 0.000 claims 1
- ZXVPQAYRROPSID-UHFFFAOYSA-N n-cyclobutyl-n-(2-hydroxyethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCO)C1CCC1 ZXVPQAYRROPSID-UHFFFAOYSA-N 0.000 claims 1
- MIUQCLGIQMDLRR-UHFFFAOYSA-N n-cyclobutyl-n-(2-imidazol-1-ylethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C1CCC1)CCN1C=CN=C1 MIUQCLGIQMDLRR-UHFFFAOYSA-N 0.000 claims 1
- IXHWJTUUJORBAX-UHFFFAOYSA-N n-cyclobutyl-n-(2-methoxyethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCOC)C1CCC1 IXHWJTUUJORBAX-UHFFFAOYSA-N 0.000 claims 1
- XQLOPSDMRSFQOL-UHFFFAOYSA-N n-cyclobutyl-n-(2-morpholin-4-ylethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C1CCC1)CCN1CCOCC1 XQLOPSDMRSFQOL-UHFFFAOYSA-N 0.000 claims 1
- ICBUVEURXRUENW-UHFFFAOYSA-N n-cyclobutyl-n-[3-(dimethylamino)propyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CCCN(C)C)C1CCC1 ICBUVEURXRUENW-UHFFFAOYSA-N 0.000 claims 1
- POLPFFPBRUEOFX-UHFFFAOYSA-N n-cyclobutyl-n-ethyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(CC)C1CCC1 POLPFFPBRUEOFX-UHFFFAOYSA-N 0.000 claims 1
- GRPZFLWGRGVWBR-UHFFFAOYSA-N n-cyclobutyl-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C1CCC1 GRPZFLWGRGVWBR-UHFFFAOYSA-N 0.000 claims 1
- WBNLSRCHYHPRAV-UHFFFAOYSA-N n-cyclopentyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)NC1CCCC1 WBNLSRCHYHPRAV-UHFFFAOYSA-N 0.000 claims 1
- SZRDJSMRSZTEAJ-UHFFFAOYSA-N n-cyclopentyl-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C1CCCC1 SZRDJSMRSZTEAJ-UHFFFAOYSA-N 0.000 claims 1
- CMWWGIDJXSETJU-UHFFFAOYSA-N n-cyclopropyl-n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C1CC1 CMWWGIDJXSETJU-UHFFFAOYSA-N 0.000 claims 1
- JKJTWLYTMLZRNQ-UHFFFAOYSA-N n-ethyl-n-propan-2-yl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound CCN(C(C)C)S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 JKJTWLYTMLZRNQ-UHFFFAOYSA-N 0.000 claims 1
- AVQZNUCKRUYXQQ-UHFFFAOYSA-N n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound CNS(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 AVQZNUCKRUYXQQ-UHFFFAOYSA-N 0.000 claims 1
- OZGDUZIROORKOP-UHFFFAOYSA-N n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-n-(2-pyrrol-1-ylethyl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCN1C=CC=C1 OZGDUZIROORKOP-UHFFFAOYSA-N 0.000 claims 1
- ALNGQLRSOWJELW-UHFFFAOYSA-N n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-n-[(3-sulfamoylphenyl)methyl]-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1=CC=CC(S(N)(=O)=O)=C1 ALNGQLRSOWJELW-UHFFFAOYSA-N 0.000 claims 1
- VXWQQULEGHVBNQ-UHFFFAOYSA-N n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-n-[(4-sulfamoylphenyl)methyl]-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1=CC=C(S(N)(=O)=O)C=C1 VXWQQULEGHVBNQ-UHFFFAOYSA-N 0.000 claims 1
- AAAGJSQSBKHFJZ-UHFFFAOYSA-N n-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-n-[[4-(trifluoromethoxy)phenyl]methyl]-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1=CC=C(OC(F)(F)F)C=C1 AAAGJSQSBKHFJZ-UHFFFAOYSA-N 0.000 claims 1
- WJMJAADAYUHNKO-UHFFFAOYSA-N n-methyl-n-(1,2-oxazol-5-ylmethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1=CC=NO1 WJMJAADAYUHNKO-UHFFFAOYSA-N 0.000 claims 1
- HDCSBLGQWXCZAQ-UHFFFAOYSA-N n-methyl-n-(1-methylsulfonylazetidin-3-yl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C1CN(S(C)(=O)=O)C1 HDCSBLGQWXCZAQ-UHFFFAOYSA-N 0.000 claims 1
- HHJADTCNYXTKNT-UHFFFAOYSA-N n-methyl-n-(2-phenoxyethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCOC1=CC=CC=C1 HHJADTCNYXTKNT-UHFFFAOYSA-N 0.000 claims 1
- JKIBSGYPVPXSSJ-UHFFFAOYSA-N n-methyl-n-(2-phenylethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCC1=CC=CC=C1 JKIBSGYPVPXSSJ-UHFFFAOYSA-N 0.000 claims 1
- MOYZRHBDPGHISH-UHFFFAOYSA-N n-methyl-n-(2-phenylpropyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C=1C=CC=CC=1C(C)CN(C)S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 MOYZRHBDPGHISH-UHFFFAOYSA-N 0.000 claims 1
- OPZXZFJPENFDEN-UHFFFAOYSA-N n-methyl-n-(2-pyrazol-1-ylethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCN1C=CC=N1 OPZXZFJPENFDEN-UHFFFAOYSA-N 0.000 claims 1
- SUNHRONPTOLOOS-UHFFFAOYSA-N n-methyl-n-(3-methylbutyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound CC(C)CCN(C)S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 SUNHRONPTOLOOS-UHFFFAOYSA-N 0.000 claims 1
- CDPCTSMMJVXMIP-UHFFFAOYSA-N n-methyl-n-(3-phenylpropyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CCCC1=CC=CC=C1 CDPCTSMMJVXMIP-UHFFFAOYSA-N 0.000 claims 1
- NQWAGVQXZUYEDD-UHFFFAOYSA-N n-methyl-n-(oxetan-3-yl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C1COC1 NQWAGVQXZUYEDD-UHFFFAOYSA-N 0.000 claims 1
- VUHGZQGWQRJXMM-UHFFFAOYSA-N n-methyl-n-(piperidin-3-ylmethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCCNC1 VUHGZQGWQRJXMM-UHFFFAOYSA-N 0.000 claims 1
- MSLHZOFWBKGJCI-UHFFFAOYSA-N n-methyl-n-(piperidin-4-ylmethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCNCC1 MSLHZOFWBKGJCI-UHFFFAOYSA-N 0.000 claims 1
- BXXYCUSSZNLKLG-UHFFFAOYSA-N n-methyl-n-(pyridin-2-ylmethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1=CC=CC=N1 BXXYCUSSZNLKLG-UHFFFAOYSA-N 0.000 claims 1
- SYSRIKNTGFJCSF-UHFFFAOYSA-N n-methyl-n-(pyrrolidin-3-ylmethyl)-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCNC1 SYSRIKNTGFJCSF-UHFFFAOYSA-N 0.000 claims 1
- JMCQWNDAFZDTTQ-UHFFFAOYSA-N n-methyl-n-[(1-methylsulfonylpiperidin-3-yl)methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCCN(S(C)(=O)=O)C1 JMCQWNDAFZDTTQ-UHFFFAOYSA-N 0.000 claims 1
- JZLQAKGYMDVZCZ-UHFFFAOYSA-N n-methyl-n-[(1-methylsulfonylpiperidin-4-yl)methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCN(S(C)(=O)=O)CC1 JZLQAKGYMDVZCZ-UHFFFAOYSA-N 0.000 claims 1
- QMXMDZFGOZTFMB-UHFFFAOYSA-N n-methyl-n-[(1-methylsulfonylpyrrolidin-3-yl)methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCN(S(C)(=O)=O)C1 QMXMDZFGOZTFMB-UHFFFAOYSA-N 0.000 claims 1
- NQQPQVZZTCEQOU-UHFFFAOYSA-N n-methyl-n-[(1-propanoylpyrrolidin-3-yl)methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1N(C(=O)CC)CCC1CN(C)S(=O)(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 NQQPQVZZTCEQOU-UHFFFAOYSA-N 0.000 claims 1
- PKBYSESHDMNDES-UHFFFAOYSA-N n-methyl-n-[(1-propylsulfonylpyrrolidin-3-yl)methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1N(S(=O)(=O)CCC)CCC1CN(C)S(=O)(=O)N1C2(CC2)CN(C=2C=3C=CNC=3N=CN=2)CC1 PKBYSESHDMNDES-UHFFFAOYSA-N 0.000 claims 1
- WUQJAIUIPSLVMN-UHFFFAOYSA-N n-methyl-n-[(3-oxocyclobutyl)methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CC(=O)C1 WUQJAIUIPSLVMN-UHFFFAOYSA-N 0.000 claims 1
- IRCSTPRQTVOZNC-UHFFFAOYSA-N n-methyl-n-[(4-methylidenecyclohexyl)methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1CCC(=C)CC1 IRCSTPRQTVOZNC-UHFFFAOYSA-N 0.000 claims 1
- FAFXZDGVCUCCMZ-UHFFFAOYSA-N n-methyl-n-[(4-methylsulfonylphenyl)methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC1=CC=C(S(C)(=O)=O)C=C1 FAFXZDGVCUCCMZ-UHFFFAOYSA-N 0.000 claims 1
- DLQYDROUVYFJPX-OAHLLOKOSA-N n-methyl-n-[[(2r)-1-methylsulfonylpyrrolidin-2-yl]methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@H]1CCCN1S(C)(=O)=O DLQYDROUVYFJPX-OAHLLOKOSA-N 0.000 claims 1
- JCJXXXUMLHAIRS-CYBMUJFWSA-N n-methyl-n-[[(2r)-5-oxopyrrolidin-2-yl]methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@H]1CCC(=O)N1 JCJXXXUMLHAIRS-CYBMUJFWSA-N 0.000 claims 1
- DIVAVHINIHYTBQ-CQSZACIVSA-N n-methyl-n-[[(2r)-pyrrolidin-2-yl]methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@H]1CCCN1 DIVAVHINIHYTBQ-CQSZACIVSA-N 0.000 claims 1
- DLQYDROUVYFJPX-HNNXBMFYSA-N n-methyl-n-[[(2s)-1-methylsulfonylpyrrolidin-2-yl]methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@@H]1CCCN1S(C)(=O)=O DLQYDROUVYFJPX-HNNXBMFYSA-N 0.000 claims 1
- JCJXXXUMLHAIRS-ZDUSSCGKSA-N n-methyl-n-[[(2s)-5-oxopyrrolidin-2-yl]methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@@H]1CCC(=O)N1 JCJXXXUMLHAIRS-ZDUSSCGKSA-N 0.000 claims 1
- DIVAVHINIHYTBQ-AWEZNQCLSA-N n-methyl-n-[[(2s)-pyrrolidin-2-yl]methyl]-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C[C@@H]1CCCN1 DIVAVHINIHYTBQ-AWEZNQCLSA-N 0.000 claims 1
- UQPSNJBBYOKOGM-UHFFFAOYSA-N n-methyl-n-phenacyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)CC(=O)C1=CC=CC=C1 UQPSNJBBYOKOGM-UHFFFAOYSA-N 0.000 claims 1
- CIGKTCDFFAKRJN-UHFFFAOYSA-N n-methyl-n-phenyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)C1=CC=CC=C1 CIGKTCDFFAKRJN-UHFFFAOYSA-N 0.000 claims 1
- RKBWDKYOMREEBB-UHFFFAOYSA-N n-methyl-n-phenylmethoxy-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)N(C)OCC1=CC=CC=C1 RKBWDKYOMREEBB-UHFFFAOYSA-N 0.000 claims 1
- RTAKUAFBDVROFX-UHFFFAOYSA-N n-methyl-n-propan-2-yl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound CC(C)N(C)S(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 RTAKUAFBDVROFX-UHFFFAOYSA-N 0.000 claims 1
- XQOVWVQOSYRSQW-UHFFFAOYSA-N n-pentan-2-yl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound CCCC(C)NS(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 XQOVWVQOSYRSQW-UHFFFAOYSA-N 0.000 claims 1
- JJUSREYAJYCMFX-UHFFFAOYSA-N n-phenylmethoxy-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CC2(CC2)N1S(=O)(=O)NOCC1=CC=CC=C1 JJUSREYAJYCMFX-UHFFFAOYSA-N 0.000 claims 1
- OTCDORFSTSKFAZ-UHFFFAOYSA-N n-propan-2-yl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-4,7-diazaspiro[2.5]octane-4-sulfonamide Chemical compound CC(C)NS(=O)(=O)N1CCN(C=2C=3C=CNC=3N=CN=2)CC11CC1 OTCDORFSTSKFAZ-UHFFFAOYSA-N 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 125000003566 oxetanyl group Chemical group 0.000 claims 1
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims 1
- 125000006505 p-cyanobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C#N)C([H])([H])* 0.000 claims 1
- 201000001976 pemphigus vulgaris Diseases 0.000 claims 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000004344 phenylpropyl group Chemical group 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- 230000007824 polyneuropathy Effects 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- 125000000168 pyrrolyl group Chemical group 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 125000006413 ring segment Chemical group 0.000 claims 1
- 201000004700 rosacea Diseases 0.000 claims 1
- 208000008742 seborrheic dermatitis Diseases 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- NYIHEUQYLJRFCF-UHFFFAOYSA-N tert-butyl 4-[4-[2-phenylethyl(3-phenylpropyl)sulfamoyl]-4,7-diazaspiro[2.5]octan-7-yl]pyrrolo[2,3-d]pyrimidine-7-carboxylate Chemical compound N1=CN=C2N(C(=O)OC(C)(C)C)C=CC2=C1N(C1)CCN(S(=O)(=O)N(CCCC=2C=CC=CC=2)CCC=2C=CC=CC=2)C21CC2 NYIHEUQYLJRFCF-UHFFFAOYSA-N 0.000 claims 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 1
- 125000006223 tetrahydrofuranylmethyl group Chemical group 0.000 claims 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 1
- 125000006173 tetrahydropyranylmethyl group Chemical group 0.000 claims 1
- NFZLPULKDNRALQ-UHFFFAOYSA-N thiane-4-carboxamide Chemical compound NC(=O)C1CCSCC1 NFZLPULKDNRALQ-UHFFFAOYSA-N 0.000 claims 1
- YUXHURBBBVGCBC-UHFFFAOYSA-N thiolane-3-carboxamide Chemical compound NC(=O)C1CCSC1 YUXHURBBBVGCBC-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161430670P | 2011-01-07 | 2011-01-07 | |
| US61/430,670 | 2011-01-07 | ||
| PCT/EP2012/050187 WO2012093169A1 (en) | 2011-01-07 | 2012-01-06 | Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014501772A JP2014501772A (ja) | 2014-01-23 |
| JP2014501772A5 true JP2014501772A5 (enExample) | 2015-02-26 |
Family
ID=45478318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013547865A Pending JP2014501772A (ja) | 2011-01-07 | 2012-01-06 | タンパク質チロシンキナーゼ阻害薬としての新規スルファミドピペラジン誘導体およびその医薬用途 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9233964B2 (enExample) |
| EP (1) | EP2661436B1 (enExample) |
| JP (1) | JP2014501772A (enExample) |
| KR (1) | KR20140058402A (enExample) |
| CN (1) | CN103298817A (enExample) |
| AU (1) | AU2012204843A1 (enExample) |
| BR (1) | BR112013017184A2 (enExample) |
| CA (1) | CA2823935A1 (enExample) |
| MX (1) | MX2013007792A (enExample) |
| RU (1) | RU2013136906A (enExample) |
| TW (1) | TW201309703A (enExample) |
| WO (1) | WO2012093169A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6427599B2 (ja) * | 2014-05-19 | 2018-11-21 | チャンスー ヘンルイ メディシン カンパニー，リミテッド | チロシンキナーゼ阻害剤としての置換エチニルヘテロ二環式化合物 |
| SG11201608441YA (en) | 2014-06-24 | 2016-11-29 | Taiho Pharmaceutical Co Ltd | Novel pyrrolopyrimidine compound or salt thereof, pharmaceutical composition containing same, especially agent for prevention and/or treatment of tumors etc based on nae inhibitory effect |
| JP7101685B2 (ja) * | 2017-01-20 | 2022-07-15 | レオ ファーマ アクティーゼルスカブ | 新規ｊａｋキナーゼ阻害剤としての二環式アミン |
| EP3576743B1 (en) | 2017-02-03 | 2023-01-18 | LEO Pharma A/S | 5-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-5-azaspiro[2 5]octane-8-carboxylic acid derivatives as jak kinase inhibitors |
| CN108822048A (zh) * | 2018-07-23 | 2018-11-16 | 上海昌肽生物科技有限公司 | 4-(4-乙基-4,7二氮杂螺环[3,3]辛基)-2-硝基苯胺的合成工艺 |
| CN116730927A (zh) * | 2023-03-21 | 2023-09-12 | 广州佳途科技股份有限公司 | 一种新型高效合成4,7-二氮杂螺[2.5]辛烷盐酸盐的方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA005852B1 (ru) | 1998-06-19 | 2005-06-30 | Пфайзер Продактс Инк. | ПИРРОЛО[2,3-d]ПИРИМИДИНЫ |
| PA8474101A1 (es) * | 1998-06-19 | 2000-09-29 | Pfizer Prod Inc | Compuestos de pirrolo [2,3-d] pirimidina |
| EA006227B1 (ru) | 1999-12-10 | 2005-10-27 | Пфайзер Продактс Инк. | СОЕДИНЕНИЯ ПИРРОЛО[2,3-d]ПИРИМИДИНА |
| AU2002336462A1 (en) | 2001-09-06 | 2003-03-24 | Millennium Pharmaceuticals, Inc. | Piperazine and homopiperazine compounds |
| JP4768265B2 (ja) * | 2002-10-15 | 2011-09-07 | シンタ ファーマシューティカルズ コーポレーション | 新規化合物 |
| SE0301372D0 (sv) * | 2003-05-09 | 2003-05-09 | Astrazeneca Ab | Novel compounds |
| NZ590160A (en) | 2003-11-21 | 2012-07-27 | Array Biopharma Inc | AKT protein kinase inhibitors |
| JP2007512316A (ja) | 2003-11-25 | 2007-05-17 | ファイザー・プロダクツ・インク | アテローム性動脈硬化症の治療方法 |
| KR20060096153A (ko) | 2003-12-17 | 2006-09-07 | 화이자 프로덕츠 인코포레이티드 | 이식 거부 치료용 피롤로[2,3-ｄ]피리미딘 화합물 |
| JP4926943B2 (ja) * | 2004-04-13 | 2012-05-09 | シンタ ファーマシューティカルズ コーポレーション | Ｉｌ−１２産生を阻害する二塩 |
| AR054416A1 (es) | 2004-12-22 | 2007-06-27 | Incyte Corp | Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas. |
| ZA200707342B (en) | 2005-02-03 | 2009-03-25 | Vertex Pharma | Pyrrolopyrimidines useful as inhibitors of protein kinase |
| WO2006091450A1 (en) * | 2005-02-18 | 2006-08-31 | Lexicon Genetics Incorporated | 4-piperidin-1-yl-7h-pyrrolo[2,3-d]pyrimidine compounds |
| JP2008545660A (ja) | 2005-05-20 | 2008-12-18 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼ阻害剤として有用なピロロピリジン化合物 |
| CN102127078A (zh) | 2005-07-14 | 2011-07-20 | 安斯泰来制药株式会社 | Janus激酶3的杂环类抑制剂 |
| CA2639924C (en) * | 2006-02-02 | 2017-01-10 | Millennium Pharmaceuticals, Inc. | Purinyl-and pyrrolo[2,3-d]pyrimidinyl cyclopentyl compounds and their use as inhibitors of e1 activating enzymes |
| MX2008011559A (es) | 2006-03-11 | 2008-11-25 | Vernalis R&D Ltd | Derivados de pirrolopirimidina utilizados como inhibidores de hsp90. |
| GB0604944D0 (en) * | 2006-03-11 | 2006-04-19 | Vernalis R&D Ltd | Pyrrolopyrimidine compounds |
| SG170828A1 (en) * | 2006-04-05 | 2011-05-30 | Vertex Pharmaceuticals Inc Us | Deazapurines useful as inhibitors of janus kinases |
| AU2008240188A1 (en) * | 2007-04-13 | 2008-10-23 | Supergen, Inc. | Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders |
| DK2188289T3 (en) | 2007-08-08 | 2016-01-25 | Lexicon Pharmaceuticals Inc | (7H-Pyrrolo [2,3-D] pyrimidin-4-yl) -piperazines as kinase inhibitors for the treatment of cancer and inflammation |
| US9346809B2 (en) * | 2009-07-08 | 2016-05-24 | Leo Pharma A/S | Heterocyclic compounds as JAK receptor and protein tyrosine kinase inhibitors |
-
2012
- 2012-01-06 RU RU2013136906/04A patent/RU2013136906A/ru not_active Application Discontinuation
- 2012-01-06 WO PCT/EP2012/050187 patent/WO2012093169A1/en not_active Ceased
- 2012-01-06 US US13/977,408 patent/US9233964B2/en not_active Expired - Fee Related
- 2012-01-06 AU AU2012204843A patent/AU2012204843A1/en not_active Abandoned
- 2012-01-06 CA CA2823935A patent/CA2823935A1/en not_active Abandoned
- 2012-01-06 MX MX2013007792A patent/MX2013007792A/es not_active Application Discontinuation
- 2012-01-06 CN CN2012800048283A patent/CN103298817A/zh active Pending
- 2012-01-06 BR BR112013017184A patent/BR112013017184A2/pt not_active IP Right Cessation
- 2012-01-06 EP EP12700266.5A patent/EP2661436B1/en not_active Not-in-force
- 2012-01-06 KR KR1020137020834A patent/KR20140058402A/ko not_active Withdrawn
- 2012-01-06 JP JP2013547865A patent/JP2014501772A/ja active Pending
- 2012-01-09 TW TW101100842A patent/TW201309703A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014501772A5 (enExample) | ||
| KR102534028B1 (ko) | 트리아졸로피리미딘 화합물 및 그의 용도 | |
| JP6229042B2 (ja) | ビヘテロアリール化合物及びその使用 | |
| JP4638355B2 (ja) | チアゾール誘導体 | |
| JP2010510319A5 (enExample) | ||
| HRP20130106T1 (hr) | Imidazotriazini i imidazopirimidini kao inhibitori kinaze | |
| JP2012532152A5 (enExample) | ||
| HRP20180357T1 (hr) | Inhibitori bromodomene | |
| JP2016517878A5 (enExample) | ||
| JP2019512482A5 (enExample) | ||
| RU2019115115A (ru) | Производные пиперидина в качестве ингибиторов убиквитин-специфической протеазы 7 | |
| CN101605540A (zh) | 使用mek抑制剂的方法 | |
| JP2016523911A5 (enExample) | ||
| JP2019504901A5 (enExample) | ||
| JP2009513575A5 (enExample) | ||
| RU2015121374A (ru) | Ингибиторы alk-киназы | |
| RU2014150049A (ru) | Ингибиторы nampt | |
| JP2018522929A5 (enExample) | ||
| JP2018536684A5 (enExample) | ||
| RU2019123319A (ru) | Пиразолопиримидины и способы их применения | |
| JP2013533868A5 (enExample) | ||
| RU2013136906A (ru) | Новые производные сульфамидпиперазина в качестве ингибиторов протеинтирозинкиназы и их фармацевтическое применение | |
| RU2017117248A (ru) | Этил-n-boc-пиперидинил-пиразоло-пиридоны в качестве ингибиторов янус-киназы | |
| JP2017519023A5 (enExample) | ||
| RU2015116816A (ru) | Производное имидазола |